Gotham Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Gotham Asset Management's HRMY Position: Q3 2026 in Review
Gotham Asset Management increased its Harmony Biosciences (HRMY) stake by 20% in Q3 2026, buying an estimated $282K and bringing the position to 43,165 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1280.
Gotham Asset Management first reported a position in HRMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.81M in Q1 2024. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Gotham Asset Management held 43,165 shares of Harmony Biosciences worth $1.69M as of Q3 2026.
- Gotham Asset Management bought 7,299 Harmony Biosciences shares in Q3 2026, an estimated $282K.
- Harmony Biosciences made up ﹤0.01% of Gotham Asset Management's portfolio in Q3 2026, its #1280 holding.
- Gotham Asset Management first reported a position in Harmony Biosciences in Q3 2022 and has held it in 16 quarters since.
- Gotham Asset Management's Harmony Biosciences position peaked at $2.81M in Q1 2024.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.